LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma
Clinical trial NCT06623461 · RECRUITING
Trial details
- NCT number
- NCT06623461
- Sponsor
- Canadian Cancer Trials Group
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-07
- Primary completion
- 2028-12-31
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.